Detalles de la búsqueda
1.
Avelumab vs Standard Second-Line Chemotherapy in Patients With Metastatic Colorectal Cancer and Microsatellite Instability: A Randomized Clinical Trial.
JAMA Oncol
; 9(10): 1356-1363, 2023 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37535388
2.
Avelumab versus standard second line treatment chemotherapy in metastatic colorectal cancer patients with microsatellite instability: The SAMCO-PRODIGE 54 randomised phase II trial.
Dig Liver Dis
; 53(3): 318-323, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33359404
3.
Pembrolizumab with Capox Bevacizumab in patients with microsatellite stable metastatic colorectal cancer and a high immune infiltrate: The FFCD 1703-POCHI trial.
Dig Liver Dis
; 53(10): 1254-1259, 2021 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-34215534
4.
Three Versus 6 Months of Oxaliplatin-Based Adjuvant Chemotherapy for Patients With Stage III Colon Cancer: Disease-Free Survival Results From a Randomized, Open-Label, International Duration Evaluation of Adjuvant (IDEA) France, Phase III Trial.
J Clin Oncol
; 36(15): 1469-1477, 2018 05 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-29620995
Resultados
1 -
4
de 4
1
Próxima >
>>